Marketable Securities, Current in USD of Gain Therapeutics, Inc. from Q2 2022 to Q1 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of investment in marketable security, classified as current.
Summary: Gain Therapeutics, Inc. quarterly Marketable Securities, Current history and change rate from Q2 2022 to Q1 2024.
Gain Therapeutics, Inc. Marketable Securities, Current for the quarter ending 31 Mar 2024 was $2,019,414, a 82.9% decline year-over-year.

Marketable Securities, Current, Quarterly (USD)

Marketable Securities, Current, YoY Quarterly Change (%)

Gain Therapeutics, Inc. Quarterly Marketable Securities, Current (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q1 2024	$2,019,414	-$9,808,114	-82.9%	31 Mar 2024	10-Q	14 May 2024	2024	Q1
Q4 2023	$4,999,704	-$7,827,250	-61%	31 Dec 2023	10-K	27 Mar 2025	2024	FY
Q3 2023	$7,960,311	-$3,890,303	-32.8%	30 Sep 2023	10-Q	14 Nov 2023	2023	Q3
Q2 2023	$9,873,209	-$66,287	-0.67%	30 Jun 2023	10-Q	10 Aug 2023	2023	Q2
Q1 2023	$11,827,528			31 Mar 2023	10-Q	12 May 2023	2023	Q1
Q4 2022	$12,826,954			31 Dec 2022	10-K	26 Mar 2024	2023	FY
Q3 2022	$11,850,614			30 Sep 2022	10-Q	10 Nov 2022	2022	Q3
Q2 2022	$9,939,496			30 Jun 2022	10-Q	08 Aug 2022	2022	Q2

* An asterisk sign (*) next to the value indicates that the value is likely invalid.